CF
LLY icon

Corebridge Financial’s Eli Lilly LLY Stock Holding History

Corebridge Financial’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-201,235
Closed -$166M – 1531
2025
Q1 		$166M Sell
201,235
-8,835
-4% -$7.35M 0.96% 12
2024
Q4 		$162M Sell
210,070
-79
-0% -$65.4K 0.88% 11
2024
Q3 		$186M Sell
210,149
-9,420
-4% -$8.47M 0.99% 11
2024
Q2 		$199M Buy
+219,569
New +$176M 1.09% 9

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Corebridge Financial's LLY Position: Q2 2025 in Review

Corebridge Financial sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 201,235 shares — an estimated $166M sold.

Corebridge Financial first reported a position in LLY in Q2 2024 and held it in 4 quarters. The position peaked at $199M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Corebridge Financial reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 201,235 Eli Lilly shares in Q2 2025, an estimated $166M.
  • Corebridge Financial first reported a position in Eli Lilly in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Eli Lilly position peaked at $199M in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.